These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24790866)
1. Improvement of visual acuity based on optical coherence tomography patterns following intravitreal bevacizumab treatment in patients with diabetic macular edema. Cheema HR; Al Habash A; Al-Askar E Int J Ophthalmol; 2014; 7(2):251-5. PubMed ID: 24790866 [TBL] [Abstract][Full Text] [Related]
2. Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up. Arevalo JF; Sanchez JG; Fromow-Guerra J; Wu L; Berrocal MH; Farah ME; Cardillo J; Rodríguez FJ; Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):735-43. PubMed ID: 19189118 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
4. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Sanchez JG; Wu L; Maia M; Alezzandrini AA; Brito M; Bonafonte S; Lujan S; Diaz-Llopis M; Restrepo N; Rodríguez FJ; Udaondo-Mirete P; Ophthalmology; 2009 Aug; 116(8):1488-97, 1497.e1. PubMed ID: 19545900 [TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema. Kim M; Lee P; Kim Y; Yu SY; Kwak HW Ophthalmologica; 2011; 226(3):138-44. PubMed ID: 21822008 [TBL] [Abstract][Full Text] [Related]
6. Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics. Rush RB; Simunovic MP; Vandiver L; Aragon AV; Ysasaga JE Retina; 2014 May; 34(5):846-52. PubMed ID: 24240560 [TBL] [Abstract][Full Text] [Related]
7. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Kang HM; Chung EJ; Kim YM; Koh HJ Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment clinical variables associated with the response to intravitreal bevacizumab (Avastin) injection in patients with persistent diabetic macular edema. Warid Al-Laftah FA; Elshafie M; Alhashimi M; Pai A; Farouq M Saudi J Ophthalmol; 2010 Oct; 24(4):133-8. PubMed ID: 23960890 [TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography patterns of diabetic macular edema and treatment response to bevacizumab: a short-term study. Sharma S; Karki P; Joshi SN; Parajuli S Ther Adv Ophthalmol; 2022; 14():25158414221074519. PubMed ID: 35387237 [TBL] [Abstract][Full Text] [Related]